Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)
NCT ID: NCT01496053
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
100 participants
INTERVENTIONAL
2011-12-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A prospective randomised study comparing the mushroom extract with placebo.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)
NCT01106742
Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis
NCT04029649
The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
NCT04329481
Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
NCT04000139
Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis
NCT02442960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AndoSan
AndoSan given to IBD patients
AndoSan
AndoSan 30 ml x 2 for 21 days
Sugar extract
Sugar extract to IBD patients
Sugar Extract
Sham comparator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AndoSan
AndoSan 30 ml x 2 for 21 days
Sugar Extract
Sham comparator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* biological treatment,
* pregnancy.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ImmunoPharma AS
INDUSTRY
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Egil Johnson
MD, Phd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Egil Johnson, MD. Phd
Role: PRINCIPAL_INVESTIGATOR
Ullevaal University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital, Ulleval
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E. Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study. PLoS One. 2016 Jul 14;11(7):e0159288. doi: 10.1371/journal.pone.0159288. eCollection 2016.
Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E. Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study. PLoS One. 2016 Mar 2;11(3):e0150191. doi: 10.1371/journal.pone.0150191. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AbM2012-IBD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.